Ninepoint Partners LP Makes New Investment in Aehr Test Systems $AEHR
Ninepoint Partners LP has acquired a new stake of 9,996 shares in Aehr Test Systems (NASDAQ:AEHR) during the second quarter, valued at approximately $960,000. Institutional investors now own 69.69% of the company, while insiders have recently sold shares totaling $13.83 million. Analysts generally maintain a "Buy" rating for AEHR, with an average price target of $136.67.
Aehr Test Systems Sinks 10%, Teradyne Falls 5%, FormFactor Drops 6%: What's Hitting These Semiconductor Test Equipment Stocks?
Shares of semiconductor test equipment companies like Aehr Test Systems, Teradyne, FormFactor, and Cohu are experiencing significant declines, with Aehr Test Systems leading the drop by 10%. This downturn is attributed to sector-wide profit-taking after substantial year-to-date gains, rather than company-specific catalysts or broader market issues, as evidenced by the much smaller decline in the SPDR S&P Semiconductor ETF. The selling appears concentrated on AI hardware winners, suggesting a rotation out of these high-performing stocks.
GSA Capital Partners LLP Takes $926,000 Position in Aehr Test Systems $AEHR
GSA Capital Partners LLP has acquired a new position in Aehr Test Systems, purchasing 9,639 shares valued at approximately $926,000. This comes as other institutional investors have also adjusted their holdings, with 69.69% of the stock owned by institutions. Despite significant insider selling totaling $13.8 million over the last three months, analysts maintain a "Buy" rating for AEHR with a consensus price target of $136.67.
Aehr Test Systems | 4: Statement of changes in beneficial ownership of securities-Officer ROGERS VERNON
This article reports a change in beneficial ownership of securities for Aehr Test Systems, specifically involving Officer Vernon Rogers. The filing is identified as a Form 4 statement.
Royal Bank of Canada Buys 7,968 Shares of Aehr Test Systems $AEHR
Royal Bank of Canada increased its stake in Aehr Test Systems (NASDAQ:AEHR) by 15.3% in the first quarter, acquiring an additional 7,968 shares, bringing its total holdings to 59,939 shares valued at $2.22 million. Institutional ownership of Aehr Test Systems is substantial at 69.69%, with Vanguard, Halter Ferguson Financial, and UBS also increasing their positions. Despite broad positive analyst sentiment with an average "Buy" rating and a target price of $136.67, insiders have sold a significant 109,475 shares worth $13.83 million in the past 90 days.
AEHR TEST SYSTEMS (AEHR) exec sells 5,994 shares; no 10b5-1 plan noted
Vernon Rogers, Executive VP of Sales & Marketing at AEHR Test Systems (AEHR), sold a total of 5,994 shares of common stock in August 2026 across three separate transactions. The sales occurred on August 14 and August 17, with prices ranging from $134.00 to $143.77 per share. Notably, the sales were not conducted under a Rule 10b5-1 trading plan, and a portion of the reported shares included unvested restricted stock units.
Aehr Test Systems Exec VP of Sales & Mktg. Sold Shares Worth Over $847K
Vernon Rogers, the Exec VP of Sales & Mktg. at Aehr Test Systems (AEHR), sold 5,994 shares of common stock in three separate transactions on August 14 and August 17, 2026. The sales, executed at an average price of $141.33 per share, totaled $847,217. Following these transactions, Rogers directly owns 186,232 shares.
Aehr Test Systems Slides as Profit-Taking Hits Recent AI-Driven Rally
Aehr Test Systems (AEHR) shares dropped 14.9% today, likely due to profit-taking following a recent rally driven by AI interest, despite the company reporting strong orders, backlog growth, and a positive fiscal 2027 outlook. The selloff occurred without new negative company-specific news. Insider trading data shows significant sales by executives, and institutional investors also made large moves in the stock.
Rice Hall James & Associates LLC Purchases Shares of 87,546 Aehr Test Systems $AEHR
Rice Hall James & Associates LLC recently acquired 87,546 shares of Aehr Test Systems (NASDAQ:AEHR) in the second quarter, a new position valued at approximately $8.41 million. Institutional investors collectively own 69.69% of the semiconductor company. Analyst sentiment is largely positive with a consensus "Buy" rating, despite recent insider share sales totaling over $13.8 million.
Is Aehr Test Systems (AEHR) Overvalued As Its Share Price Momentum Surges?
Aehr Test Systems (AEHR) has experienced significant share price momentum, rising 8.6% in one day and 80% over the past month, reaching $145.61. Despite this surge, a widely followed valuation narrative suggests the company is 697% overvalued, with a fair value pegged at $18.27, based on ambitious revenue forecasts and future earnings multiples. The article advises investors to scrutinize the underlying data and risks to form their own conclusions given the mixed opinions on its valuation.
AEHR (NASDAQ: AEHR) insider lines up new stock sale after $273K trade
AEHR insider Vernon I. Rogers has filed a Form 144 to sell 3,994 shares of common stock, valued at approximately $574,217.38, through Fidelity Brokerage Services LLC on August 17, 2026. This follows a previous sale of 2,000 shares for $273,000 on August 14, 2026. The filing also details multiple restricted stock vesting events that occurred in 2025 as part of his compensation.
Weekly Recap: Aehr Test Systems $22M wafer order and Jefferies $175 target
Aehr Test Systems (AEHR) secured a $22 million order for FOX-XP WLBI systems, WaferPak contactors, and Auto Aligners to test nine 300mm wafers for a Taiwanese high-volume partner, with shipments spanning six months. Simultaneously, Jefferies initiated coverage on AEHR with a $175 price target. This recap summarizes these two key financial developments for the company.
The Manufacturers Life Insurance Company Makes New Investment in Aehr Test Systems $AEHR
The Manufacturers Life Insurance Company recently acquired 7,856 shares of Aehr Test Systems (NASDAQ:AEHR), valued at approximately $291,000, amid strong AI-related demand benefiting the semiconductor company. While Aehr Test Systems is experiencing record bookings, a substantial backlog, and positive revenue guidance, concerns about its elevated valuation and insider selling pose potential risks. Analysts maintain a "Buy" rating with a consensus price target of $136.67.
Aehr Test Systems VP Alistair Sporck sells $108,490 in common stock
Alistair N Sporck, VP of Contactor Business Unit at Aehr Test Systems (NASDAQ:AEHR), sold 1,000 shares of common stock for $108,490. This transaction occurred on August 10, 2026, with each share priced at $108.49. Following the sale, Sporck still directly holds 22,547 shares and indirectly owns 5,177 shares through a trust, while the stock has seen a significant 632% return over the past year.
Aehr Test Systems (NASDAQ:AEHR) Rating Increased to Strong-Buy at Jefferies Financial Group
Jefferies Financial Group has upgraded Aehr Test Systems (NASDAQ:AEHR) to a "strong-buy" rating, joining other analysts in a bullish outlook, with a consensus price target of $136.67. The company's stock opened at $134.06 and is near its 52-week high, supported by recent AI-related orders and strong bookings despite insider selling. Aehr Test Systems develops semiconductor test and burn-in equipment for integrated circuits, focusing on wafer-level reliability and functional testing.
Penn Capital Management Company LLC Makes New Investment in Aehr Test Systems $AEHR
Penn Capital Management Company LLC has made a new investment in Aehr Test Systems (NASDAQ:AEHR), acquiring 150,547 shares worth approximately $14.5 million, giving it a 0.46% stake. Institutional investors now own 69.69% of the company, which has an average "Buy" rating and a $136.67 price target due to strong AI-related demand and record bookings. Despite positive analyst sentiment and robust orders, insider selling of 109,475 shares worth $13.8 million suggests some profit-taking.
Aehr test systems director Rhea Posedel sells $836,220 in stock
Aehr Test Systems director Rhea J. Posedel sold 5,973 shares of the company's common stock for a total of $836,220 on August 14, 2026. This transaction occurred near the stock's 52-week high after a significant surge in value. Following the sale, Posedel retains substantial direct and indirect holdings in the company.
Aehr Test Systems Insiders Sold Shares Worth Over $2M
Two insiders at Aehr Test Systems (AEHR) recently sold shares totaling over $2 million. Alberto Salamone, EVP of Ppbi Business, sold 9,672 shares for $1,235,287, and Director Howard T. Slayen sold shares worth $758,264. Both sales were reported through SEC Form 4 filings.
AWM Investment Company (AEHR) discloses 374,808-share, 1.1% position in AEHR
AWM Investment Company, Inc. has filed an amended Schedule 13G disclosing a beneficial ownership of 374,808 shares of AEHR Test Systems' common stock, representing 1.1% of the class. The shares are held across four Special Situations funds, with AWM exercising sole voting and dispositive power. This filing indicates that AWM's ownership is now 5% or less of AEHR's outstanding common stock.
Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year.
Aehr Test Systems (NASDAQ:AEHR) shares rose significantly on Friday after Jefferies initiated coverage with a Buy rating and a $175 price target, highlighting the company's strong position in the semiconductor testing market driven by AI chip complexity. The stock is now up over 500% year-to-date, fueled by increasing demand for intensive testing of AI accelerators and the diversification of its revenue mix away from a single customer. Despite its impressive rally and industry tailwinds, the article cautions investors about extreme valuation risk due to the company's small market cap, lumpy revenue, high beta, and ongoing insider selling.
Aehr Test Systems surges after Jefferies initiates with bullish views
Aehr Test Systems (AEHR) saw its shares jump by about 10% on Friday after Jefferies initiated coverage of the company with a Buy rating. The investment bank set a price target of $175 for AEHR, highlighting the company's unique position as the sole vendor offering both wafer- and package-level testing solutions.
Aehr Test Systems (AEHR) Is Up 23.6% After Major AI Wafer Burn-In Capacity Expansion News
Aehr Test Systems (AEHR) saw its stock rise by 23.6% following news of a US$22 million follow-on production order for its FOX-XP wafer-level burn-in systems from a leading AI processor customer. This order, for high-volume manufacturing in Taiwan, reinforces the company's critical role in advanced AI chip production and marks a return to profitability and record bookings. While the news is positive, investors are cautioned to consider customer concentration risks and high price-to-book multiples, suggesting the stock might already reflect these developments.
Aehr Test Systems president and CEO Gayn Erickson sells $5.23m in shares
Gayn Erickson, President and CEO of Aehr Test Systems (NASDAQ:AEHR), sold 40,000 shares of company stock for a total of approximately $5.23 million on August 12, 2026. This insider sale follows a significant surge in AEHR's stock price, which has increased 554% over the past year. Despite the sale, Erickson still holds a substantial number of shares directly and indirectly, while the company recently reported strong financial results and secured new production orders.
Aehr Test Systems Chief Operating Officer Sold Shares Worth Over $1.9M
Aehr Test Systems' Chief Operating Officer, Engineer Adil, sold 15,000 shares of the company's common stock in two direct transactions on August 12, 2026. The total value of these sales exceeded $1.9 million, at a weighted average price of $131.025 per share. Following these transactions, Engineer Adil directly owns 46,977 shares, including unvested restricted stock units.
Aehr CEO and CFO will hold virtual investor meetings Aug. 19
Aehr Test Systems will participate in the 7th Annual Needham Virtual Semiconductor and SemiCap 1x1 Conference on August 19, 2026. President and CEO Gayn Erickson and CFO Chris Siu will hold virtual one-on-one meetings with investors to discuss the company's test and burn-in solutions for AI processors, silicon photonics, and other semiconductor devices. The announcement highlights Aehr's expanding role in enabling next-generation semiconductor technologies and mentions a positive market reaction following this news.
Aehr Test Systems to Participate in the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19
Aehr Test Systems (NASDAQ: AEHR) announced its participation in the 7th Annual Needham Virtual Semiconductor and SemiCap 1x1 Conference on August 19, 2026. President and CEO Gayn Erickson and CFO Chris Siu will host virtual meetings to discuss Aehr's expanding role in semiconductor testing for AI, silicon photonics, and automotive markets, highlighting their complete turnkey solutions for quality, reliability, and yield improvement.
Aehr Test Systems (AEHR) Is Up 30.8% After Securing Major AI Chip Order And 2027 Outlook
Aehr Test Systems (AEHR) saw a 30.8% stock increase following a strong fiscal fourth quarter, return to profitability, and bullish fiscal 2027 revenue guidance. The company secured a US$22 million follow-on production order for its FOX-XP wafer-level burn-in platform from a lead AI processor customer, validating its technology for high-volume AI chip manufacturing. This order reinforces Aehr's investment thesis that wafer-level burn-in will be critical for qualifying high-end AI and photonics chips at scale, despite the company's small size and premium valuation.
AEHR TEST SYSTEMS SEC Filing (Aug 12, 2026)
This article details an SEC Form 144 filing by AEHR Test Systems (AEHR) on August 12, 2026. The filing indicates a proposed sale of 8,413 shares of common stock with an aggregate market value of $1,093,690.00, acquired through compensation on April 20, 2021. The sale is to be handled by Oppenheimer & Co, Inc. and will occur on Nasdaq.
Why is Aehr Test Systems stock surging today?
Aehr Test Systems (AEHR) stock surged over 10% after announcing a $22 million follow-on production order for its FOX-XP wafer-level burn-in systems and related components from a lead AI processor customer. This news comes on the heels of the company's strong Q4 2026 results, record bookings, substantial backlog, and aggressive fiscal 2027 revenue guidance, all contributing to elevated investor confidence and pushing the stock to a new 52-week high.
Comments Off on Aehr Receives $22 Million Follow-On Order for AI Processor Wafer-Level Burn-In Systems
Aehr Test Systems announced a $22 million follow-on production order from its lead AI processor customer for wafer-level burn-in (WLBI) systems. This order includes multiple fully automated FOX-XP™ WLBI systems and proprietary FOX WaferPak™ components, designed to expand the customer's production capacity for advanced AI training and inference processors. Aehr expects to ship these systems over the next six months, highlighting increasing industry interest in WLBI for high-performance computing devices due to the rising complexity and value of advanced AI semiconductor packages.
AEHR TEST SYSTEMS (AEHR) VP Sporck sells 1,000 shares, retains over 27,000
Alistair N. Sporck, VP Contactor Business Unit at AEHR TEST SYSTEMS, sold 1,000 shares of common stock on August 10, 2026, at $108.49 per share. Following this transaction, Sporck directly holds 22,547 shares and indirectly holds 5,177 shares through a trust, totaling over 27,000 shares. The sale is categorized as a moderate impact and negative sentiment filing according to StockTitan's Rhea-AI.
AEHR Stock Surges As Earnings Beat Fuels Hypergrowth Bets
Aehr Test Systems (AEHR) stock surged over 9% after reporting strong fiscal Q4 earnings, beating EPS expectations with $0.11 and achieving 33% revenue growth. The company also announced record bookings and an effective backlog of approximately $100M, leading to an aggressive fiscal 2027 revenue guidance of $130–$150M. This hypergrowth projection, driven by new silicon carbide orders for EV programs and silicon photonics demand for AI data centers, has led multiple firms to raise AEHR's price targets.
The Biggest Market Movers: Aehr Test Systems Climbs on Strong Earnings
Aehr Test Systems (NASDAQ:AEHR) surged 6.1% in midday trading on Tuesday, extending its strong performance this summer, fueled by its AI burn-in and silicon photonics story. The company reported robust fiscal Q4 results, with revenue of $18.84 million and net income of $1.39 million, and projected fiscal 2027 revenue guidance of $130 million to $150 million, implying significant year-over-year growth. Despite its high price-to-sales ratio and insider selling, the company's strong backlog and positioning in ramping markets suggest potential upside, although its volatility reflects the dynamic nature of the optical interconnects market.
AEHR|Aehr Test Systems|Price:113.490|Chg%:+7.290
This article provides a detailed overview of Aehr Test Systems (AEHR) stock, including its live price, market data, key figures, and technical analysis. It highlights the company's strong stock performance, high analyst rating of "Buy," and a target price of $115.00. The article also describes Aehr Test Systems' products, which are semiconductor test solutions, and lists its major shareholders.
Aehr Test Systems | 144: Notice of proposed sale of securities pursuant to Rule 144
This document is a Rule 144 notice filed by Aehr Test Systems, indicating a proposed sale of securities. This filing is a regulatory requirement under the Securities Act of 1933, which allows public resale of restricted and control securities if certain conditions are met.
AEHR (AEHR) insider files to sell 1,000 common shares under Rule 144
Alistair N. Sporck, an insider at AEHR Test Systems (AEHR), has filed a notice to sell 1,000 common shares under Rule 144 through Fidelity Brokerage Services on or after August 10, 2026. The filing also indicates that 1,000 shares from restricted stock vested on July 1, 2026, as compensation, and discloses a prior sale of 2,000 shares for $201,916.91 on August 4, 2026. The impact and sentiment of this filing are deemed neutral.
Aehr Test Systems (AEHR) Files Shelf Registration On A Rally That Looks Fully Valued
Aehr Test Systems (AEHR) has filed an omnibus shelf registration, allowing it flexibility to raise capital through various securities. Despite a recent sharp rally, the company is considered "464.1% Overvalued" by the most followed narrative, with a fair value of $18.27 compared to its current share price of $103.07. Investors are advised to consider potential future dilution and analyze the full financial picture beyond the AI-related hardware hype.
Aehr Test Systems (AEHR) Stock Looks Overvalued Despite Strong Returns And AI Demand
Aehr Test Systems (AEHR) has delivered significant returns over the past five years, driven partly by AI demand, but its stock now appears overvalued based on valuation checks. The company's Price-to-Book ratio of 15.3x is substantially higher than the semiconductor industry average, suggesting that current expectations are already high. The article questions whether future growth, particularly from silicon photonics and AI networking orders, will be sufficient to justify its current premium valuation and broad gap to sector norms.
Aehr Test Systems (AEHR) Stock Looks Overvalued Despite Strong Returns And AI Demand
Aehr Test Systems (AEHR) has seen significant returns over the past five years, but its stock now appears overvalued based on traditional metrics like the price-to-book ratio. Despite strong demand driven by AI networking, the company's valuation gap compared to industry averages suggests that much of the future growth potential is already priced in, leaving less margin for error for investors. The article raises questions about the long-term durability of AI-driven demand and its ability to sustain the current premium valuation.
Aehr Test Systems (AEHR) Stock Looks Overvalued Despite Strong Returns And AI Demand
Aehr Test Systems (AEHR) has seen significant returns over the past five years, driven partly by AI networking demand. However, the stock is currently deemed overvalued by Simply Wall St's metrics, trading at a high price-to-book ratio compared to industry averages. While future demand for silicon photonics tied to AI could justify the valuation, the current price reflects substantial expectations and leaves little margin for error.
Aehr Test Systems | 4: Statement of changes in beneficial ownership of securities-Officer SPORCK ALISTAIR N
This document, filed by Aehr Test Systems, is a Statement of Changes in Beneficial Ownership of Securities (Form 4) for Officer Alistair N. Sporck. It reports modifications to his beneficial ownership of the company's securities.
Aehr Test Systems (AEHR) VP discloses 2,000-share sale
Aehr Test Systems' VP of Contactor Business Unit, Alistair N. Sporck, sold 2,000 shares of common stock on August 4, 2026, across two transactions at prices around $100. The total value of the sale was approximately $202,000. After the sale, Sporck indirectly holds 5,177 shares through a trust, with some reported amounts including unvested restricted stock units.
FMR LLC and Abigail Johnson disclose 3.2% AEHR (AEHR) ownership in 13G/A
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a passive ownership stake of 3.2% in AEHR TEST SYSTEMS (AEHR) common stock as of June 30, 2026. This equates to 1,006,830.02 beneficially owned shares, with FMR LLC holding sole voting power over 1,004,568 shares and both FMR LLC and Abigail P. Johnson having sole dispositive power over the total shares. The filing indicates that while other persons may receive dividends or sale proceeds, no single other person holds an interest exceeding five percent of AEHR's outstanding common stock.
Aehr Test Systems, Inc. (AEHR) stock price, news, quote and history
This page provides comprehensive information on Aehr Test Systems, Inc. (AEHR), including its current stock price, historical data, company profile, financial performance, and analyst insights. Aehr Test Systems specializes in providing test solutions for semiconductor devices, particularly for silicon carbide-based (SIC) and gallium nitride (GAN) power semiconductors, and is headquartered in Fremont, California. The article also includes comparative data with similar companies in the Semiconductor Equipment & Materials industry and highlights the stock's strong performance over various periods.
Aehr Test Systems (AEHR) Is Up 57.0% After New FOX-XP Silicon Photonics Order And Shelf Filing
Aehr Test Systems (AEHR) saw its stock rise 57.0% following a new FOX-XP silicon photonics order and an omnibus shelf registration filing. The order strengthens Aehr's position in the silicon photonics market, crucial for AI networking and optical applications. However, the company is currently loss-making and its valuation is seen by some as high, with the shelf filing indicating potential for future capital raises that could impact per-share economics.
Aehr Test Systems (NASDAQ: AEHR) director Slayen sells 20,000 shares
Howard T. Slayen, a director at Aehr Test Systems (NASDAQ: AEHR), sold 20,000 shares of the company's common stock on August 4, 2026, at an average price of $108.2961 per share. This open-market transaction reduced his direct holdings to 146,367 shares, which include unvested restricted stock units. The sale is classified as having a "Very High" filing impact and "Negative" sentiment by Rhea-AI.
Aehr Test Systems Director Sold Shares Worth Over $2.1M
Slayen Howard T, a Director of Aehr Test Systems, reported selling 20,000 shares of common stock on August 4, 2026. The shares were sold at $108.2961 each, totaling over $2.1 million. Following this transaction, Slayen Howard T still directly owns 146,367 common shares, including unvested restricted stock units.
Aehr Test Systems receives silicon photonics production order
Aehr Test Systems (NASDAQ:AEHR) has secured a follow-on production order from its primary silicon photonics wafer-level burn-in customer for a fully automated FOX-XP multi-wafer production burn-in system. This system, configured with nine independent WaferPak test blades, will expand the customer's manufacturing capacity for silicon photonic integrated circuits. The order is a strong indicator of the growing adoption and manufacturing scale-up of silicon photonics technology.
Aehr Test Systems Surges on Silicon Photonics Order, Signaling Manufacturing Ramp-Up
Aehr Test Systems (AEHR) shares surged after securing a follow-on production order for its FOX-XP multi-wafer burn-in system from a lead silicon photonics customer. This order signifies silicon photonics' transition from technology adoption to manufacturing scale-up, pointing to significant long-term growth for Aehr. The company expects to ship the system in the first half of 2027, further solidifying its position in the high-growth semiconductor testing equipment market, particularly for AI infrastructure and data center applications.
Aehr Test Systems wins follow-on order to expand silicon photonics production for AI applications.
Aehr Test Systems (AEHR) has received a follow-on order from a major silicon photonics customer for a FOX-XP multi-wafer burn-in system. This system will support the customer's increased production of next-generation silicon photonic integrated circuits essential for AI infrastructure. The order underscores the growing demand for wafer-level burn-in solutions and positions Aehr as a key supplier in the expanding silicon photonics market, with the system expected to ship in the first half of 2027.
